Innovation is the lifeblood of the pharmaceutical industry. The innovation power of the pharmaceutical industry mainly comes from two aspects: First, human health is constantly facing the threat of various new diseases, the pharmaceutical industry must continuously expand its own development areas; second, the mutation of bacteria and viruses The reduced efficacy of traditional medicines has prompted humans to accelerate the pace of drug upgrading.
The pharmaceutical industry is also a high-input, high-return, high-risk industry. As the pharmaceutical industry has been facing tremendous pressure for continuous innovation, pharmaceutical companies must increase their research and development efforts.
With the development of primary medical institutions, the development of emerging rural cooperative medical care and the deepening of medical reform, the demand for the pharmaceutical market in China has grown rapidly. From January to May 2011, the cumulative growth rate of the cumulative value of the pharmaceutical manufacturing industry was in a clear trend. In May, the growth rate of the total output value of the chemical manufacturing industry and the Chinese patent medicine manufacturing industry in the pharmaceutical manufacturing industry remained strong. Only the increase in the total output value of biochemical and biochemical products manufacturing industry fell back compared with the same period of last year.
From January to May 2011, China's total pharmaceutical industry achieved a total output value of 545.896 billion yuan, a year-on-year increase of 27.4%, an increase of 0.99 percentage points over the same period of 2010. In the month of May, China's total pharmaceutical industry achieved a total value of 122.241 billion yuan, a year-on-year increase of 27.91%, an increase of 2.23 percentage points over the same period in 2010. Looking at the output value from the categories of various pharmaceutical manufacturing industries:
From January to May, the total output value of the chemical manufacturing industry was 545.896 billion yuan, a year-on-year increase of 27.4%, an increase of 2.51 percentage points over the same period of 2010, and the growth rate was significantly higher. The total output value of the Chinese patent medicine manufacturing industry was 121.8 billion yuan, a year-on-year increase. 30.9%, an increase of 3.19 percentage points over the same period of 2010. Overall, the growth rate was the fastest in the industry. The total output value of biochemical and biochemical products manufacturing industry was 58.113 billion yuan, up 22.95% year-on-year, a decrease of 15.23% over the same period of 2010. Percentage point, the largest decline in growth.
In the month of May, the total output value of the chemical manufacturing industry was 60.836 billion yuan, an increase of 23.74% year-on-year, an increase of 2.45 percentage points over the same period of 2010; the total output value of the Chinese patent medicine manufacturing industry was 27.762 billion yuan, an increase of 34.63% year-on-year, an increase from 2010. The growth rate was 5.64 percentage points over the same period; the total output value of biochemical and biochemical products manufacturing industry was 13.866 billion yuan, a year-on-year increase of 27.72%, a decrease of 2.7 percentage points from the same period of 2010.
The pharmaceutical industry is also a high-input, high-return, high-risk industry. As the pharmaceutical industry has been facing tremendous pressure for continuous innovation, pharmaceutical companies must increase their research and development efforts.
With the development of primary medical institutions, the development of emerging rural cooperative medical care and the deepening of medical reform, the demand for the pharmaceutical market in China has grown rapidly. From January to May 2011, the cumulative growth rate of the cumulative value of the pharmaceutical manufacturing industry was in a clear trend. In May, the growth rate of the total output value of the chemical manufacturing industry and the Chinese patent medicine manufacturing industry in the pharmaceutical manufacturing industry remained strong. Only the increase in the total output value of biochemical and biochemical products manufacturing industry fell back compared with the same period of last year.
From January to May 2011, China's total pharmaceutical industry achieved a total output value of 545.896 billion yuan, a year-on-year increase of 27.4%, an increase of 0.99 percentage points over the same period of 2010. In the month of May, China's total pharmaceutical industry achieved a total value of 122.241 billion yuan, a year-on-year increase of 27.91%, an increase of 2.23 percentage points over the same period in 2010. Looking at the output value from the categories of various pharmaceutical manufacturing industries:
From January to May, the total output value of the chemical manufacturing industry was 545.896 billion yuan, a year-on-year increase of 27.4%, an increase of 2.51 percentage points over the same period of 2010, and the growth rate was significantly higher. The total output value of the Chinese patent medicine manufacturing industry was 121.8 billion yuan, a year-on-year increase. 30.9%, an increase of 3.19 percentage points over the same period of 2010. Overall, the growth rate was the fastest in the industry. The total output value of biochemical and biochemical products manufacturing industry was 58.113 billion yuan, up 22.95% year-on-year, a decrease of 15.23% over the same period of 2010. Percentage point, the largest decline in growth.
In the month of May, the total output value of the chemical manufacturing industry was 60.836 billion yuan, an increase of 23.74% year-on-year, an increase of 2.45 percentage points over the same period of 2010; the total output value of the Chinese patent medicine manufacturing industry was 27.762 billion yuan, an increase of 34.63% year-on-year, an increase from 2010. The growth rate was 5.64 percentage points over the same period; the total output value of biochemical and biochemical products manufacturing industry was 13.866 billion yuan, a year-on-year increase of 27.72%, a decrease of 2.7 percentage points from the same period of 2010.
Rongcheng Jingyi Oceanic Technology Company Limited , https://www.jingyifoods.cn